Bartlett JMS, Sgroi DC, Treuner K, Zhang Y, et al. Breast Cancer Index is a predictive biomarker of treatment benefit and outcome from extended tamoxifen therapy: final analysis of the Trans-aTTom study. Clin Cancer Res 2022 Feb 10. pii: 1078-0432.CCR-21-3385.
PMID: 35144966